Mitochondria and Cancer Recurrence after Liver Transplantation—What Is the Benefit of Machine Perfusion?

Mitochondria and Cancer Recurrence after Liver Transplantation—What Is the Benefit of Machine Perfusion?

Tumor recurrence after liver transplantation has been linked to multiple factors, including the recipient’s tumor burden, donor factors, and ischemia-reperfusion injury (IRI). The increasing number of livers accepted from extended criteria donors has forced the transplant community to push the devel...

Full description

Bibliographic Details
Main Authors: Alessandro Parente, Mauricio Flores Carvalho, Janina Eden, Philipp Dutkowski, Andrea Schlegel
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
hepatocellular carcinoma
liver transplantation
mitochondria
ischemia reperfusion injury
cancer recurrence
machine perfusion
Online Access:https://www.mdpi.com/1422-0067/23/17/9747

Internet

https://www.mdpi.com/1422-0067/23/17/9747

Similar Items